2024-09-24 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis

**Company Overview:** CVS Health Corp is a healthcare company that operates drugstores, pharmacies, and health insurance plans.

**Performance Analysis:**

**1. Return Comparison:**

CVS has underperformed the S&P 500 (VOO) significantly. As of today, CVS has a cumulative return of -34.31%, while VOO has a cumulative return of 132.53%. This creates a substantial gap of -166.84%, indicating that CVS has underperformed VOO by a considerable margin. 

**2. Recent Price Movement:**

* **Closing Price:** $57.51
* **5-day Moving Average:** $58.05
* **20-day Moving Average:** $57.71
* **60-day Moving Average:** $58.22

The stock price is currently trading slightly below its 5-day, 20-day, and 60-day moving averages, suggesting a short-term downtrend.

**3. Technical Indicators:**

* **RSI:** 51.25 – The RSI is in the neutral territory, indicating neither overbought nor oversold conditions.
* **PPO:** 0.17 – The PPO indicates a slight positive momentum, but it’s not a strong signal.
* **Delta_Previous_Relative_Divergence:** -2.78 – This negative value suggests a potential short-term downtrend.
* **Expected Return:** 14.57% – This represents the maximum expected return over the next 5 years based on current investment levels.

**4. Recent Earnings and Outlook:**

| Date        | EPS     | Expected EPS |
|--------------|---------|--------------|
| 2024-08-07  | 1.83    | 1.73          |
| 2024-05-01  | 1.31    | 1.7           |
| 2024-02-07  | 2.12    | 2.01          |
| 2023-11-01  | 2.21    | 2.13          |
| 2023-08-02  | 2.21    | 2.12          |

The most recent earnings report for the quarter ending August 7, 2024, showed a slight beat with an EPS of 1.83 against an expected EPS of 1.73. However, previous quarters have shown mixed performance, with some quarters missing EPS expectations. Overall, the earnings performance is not consistently strong, and the market might be cautious about future performance.

**5. Overall Analysis:**

CVS is currently underperforming the market significantly, with a substantial gap in returns compared to the S&P 500. While technical indicators suggest a slight positive momentum, the recent price movement and the relative divergence indicate a potential short-term downtrend. The latest earnings report showed a slight beat, but previous quarters have been mixed. The overall performance is not consistently strong, and the market might be cautious about future performance. 

**6. Conclusion:**

Based on the current data, CVS appears to be in a challenging position. While the stock offers a potential upside, the significant underperformance, recent price movements, and mixed earnings performance suggest that investors should proceed with caution. A deeper analysis of the company’s long-term growth prospects, competitive landscape, and potential risks is recommended before making any investment decisions. 
